Warner Bros. Discovery, Inc. Total Cost of Revenue decreased by 11.1% to $4.64B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 9.5%, from $5.13B to $4.64B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 45.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.06B | $1.53B | $1.07B | $1.24B | $6.63B | $5.63B | $6.95B | $6.69B | $6.64B | $5.31B | $5.90B | $6.06B | $6.20B | $5.18B | $5.53B | $5.13B | $5.97B | $4.56B | $5.22B | $4.64B |
| QoQ Change | — | +44.9% | -30.2% | +15.8% | +436.0% | -15.1% | +23.6% | -3.9% | -0.7% | -20.0% | +11.1% | +2.7% | +2.4% | -16.5% | +6.7% | -7.2% | +16.3% | -23.5% | +14.4% | -11.1% |
| YoY Change | — | — | — | — | +528.0% | +268.0% | +551.7% | +440.9% | +0.2% | -5.7% | -15.2% | -9.4% | -6.5% | -2.4% | -6.3% | -15.3% | -3.8% | -11.9% | -5.5% | -9.5% |